Technical Notes: References
Baquet CR, Horm JW, Gibbs T, Greenwald P. Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst. 1991; 83:551-557.
Breslow L (Chairman, Extramural Committee to Assess Measures of Progress Against Cancer). Measurement of progress against cancer: Final report to the Senate Appropriations Committee. Bethesda: National Cancer Institute; 1988.
Brookmeyer R, Damiano A. Statistical methods for short-term projections of AIDS incidence. Stat Med. 1989;8:23-34.
Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer. 1992;68:2154-9.
Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Stat Med. 1997;16:425-40.
Clegg LX, Feuer EJ, Midthune D, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94:1537-1545.
Clegg L, Gail M, Feuer EJ. Estimating the variance of disease prevalence estimates from population-based registries. Biometrics. 2002;58(3):684-8.
Day, Jennifer Cheeseman, Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050, U.S. Bureau of the Census, Current Population Reports, P25-1130, U.S. Government Printing Office, Washington, DC, 1996. Available from: http://www.census.gov/prod/1/pop/p25-1130/p251130.pdf
Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. J Natl Cancer Inst. Monogr 1961;6:101-121.
Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis. New York (NY): Wiley; 1980.
Fay MP. Estimating age conditional probability of developing disease from surveillance data. Popul Health Metr. 2004 Jul 27;2(1):6. Available from: http://www.pophealthmetrics.com/content/2/1/6
Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ. Age-conditional probabilities of developing cancer. Stat Med. 2003;22(11):1837-48.
Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival of cancer. New Engl J Med. 1985;312:1604-1608.
Feldman AR, Kessler L, Myers M, Naughton MD. The prevalence of cancer: Estimates based on the Connecticut Tumor Registry. New Engl J Med. 1986; 315:1394-1397.
Feuer EJ, Wun L-M, Boring CC. Probability of developing cancer. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, editors. Cancer Statistics Review: 1973-1989, National Cancer Institute, NIH Pub. No. 92-2789, 1992. p. 1-8.
Feuer EJ, Wun L-M, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst. 1993;85:892-897.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000.
Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics. 1999;55:1137-44.
Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC Cancer Staging Manual, 6th ed. New York (NY): Springer; 2002.
Hahn RA, Mulinare J, Teutsch SM. Inconsistencies in coding of race and ethnicity between birth and death in U.S. infants. JAMA. 1992;267:259-263.
Harris JE. Reporting delays and the incidence of AIDS. J Am Stat Assoc. 1990;85:915-924.
Howlader H, Ries LA, Stinchcomb DG, Edwards BK. The Impact of Underreported Veterans Affairs Data on National Cancer Statistics: Analysis Using Population-Based SEER Registries. JNCI. 2009 101(7):533-536.
Ingram DD, Parker JD, Schenker N, Weed JA, Hamilton B, Arias E, Madans JH. United States Census 2000 population with bridged race categories. Vital Health Stat 2. 2003 Sep;(135):1-55.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
Keyfitz N. Sampling variance of standardized mortality rates. Hum Biol. 1966;38:309-317.
Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-351.
Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods, 2nd ed. Mariotto A, Gigli A, Capocaccia R, Clegg L, Scoppa S, Ries LA, Tesauro GS, Rowland JS, Feuer EJ. Complete and limited duration prevalence estimates. SEER Cancer Statistics Review, 1973-1999. 2002;19.
Merrill RM, Feuer EJ, Capocaccia R, Mariotto A. Cancer prevalence estimates based on tumor registry data in the SEER Program. Int J Epidemiol. 2000;29:197-207.
Midthune DN, Fay MP, Clegg LX, Feuer EJ. Modeling reporting delays and reporting corrections in cancer registry data. J Am Stat Assoc. 2005;100(469):61-70.
Pagano M, Tu XM, De Gruttola V, & MaWhinney S. Regression analysis of censored and truncated data: estimating reporting-delay distributions and AIDS incidence from surveillance data. Biometrics. 1994;50:1203-1214.
Percy C, Ries LAG, Van Holten VD. The accuracy of liver cancer as the underlying cause of death on death certificates. Public Health Rep. 1990;105:361-368.
Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. 1981. Am J Public Health, 71: 3242-3250.
Percy C, Van Holten V, Muir C, editors. International Classification of Diseases for Oncology, 2nd ed. Geneva: World Health Organization;1990.
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1997. National Cancer Institute. NIH Pub. No. 00-2789. Bethesda, MD, 2000.
Robinson JG, West KK, Adlakha A. Coverage of the population in Census 2000: Results from demographic analysis. Population Res Policy Rev. 2002;21:19-38.
Rosenberg HM, Maurer JD, Sorlie PD, Johnson NJ, MacDorman MF, Hoyert DL, Spitler JF, Scott C. Quality of death rates by race and Hispanic origin: A summary of current research. Hyattsville (MD): National Center for Health Statistics; Vital and Health Statistics, Series 2, No. 128, 1999.
Snedecor GW, Cochran WG. Statistical Methods, 7th ed. Ames (IA): Iowa State University Press; 1980.
US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2002 Incidence and Mortality Web-based Report Version. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2005. Available from: http://www.cdc.gov/cancer/npcr/uscs/index.htm
US Bureau of the Census. Current Population Reports; Series P-25 No. 985. Washington (DC): US Government Printing Office; 1986.
Zelen M. Theory of early detection of breast cancer in the general population. In: Heuson J-C, Mattheiem WH, Rozencweig M, editors. Breast Cancer: Trends in Research and Treatment. New York (NY): Raven Press; 1976. p. 287-299.
Zou J, Huang L, Midthune D, Horner MJ, Krapcho M, Feuer EJ. Effect of reporting year on delay modeling. Statistical Research and Applications Branch, National Cancer Institute; 2009. Technical Report #2009-01. Available from: http://srab.cancer.gov/reports/.
